SEC Form 4 · accession 0001127602-15-021619

PALL CORP · PLL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President, BioPharmaceuticals

Period of report

Jun 29, 2015

Accepted (ET)

Jun 30, 2015 · 3:29 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000075829

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 29, 2015	M	4,984	$82.47	A	4,985	D
Common Stock	Jun 29, 2015	M	2,407	$59.75	A	7,392	D
Common Stock	Jun 29, 2015	M	8,147	$64.80	A	15,539	D
Common Stock	Jun 29, 2015	S	4,984	$124.554	D	10,555	D
Common Stock	Jun 29, 2015	S	8,147	$124.5461	D	2,408	D
Common Stock	Jun 29, 2015	S	2,407	$124.55	D	1	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (Right to Buy)^F2,F1	$82.47	Jun 29, 2015	M	4,984	D	Dec 11, 2013	Dec 11, 2020	Common Stock	4,984	9,969	D
Employee Stock Option (Right to Buy)^F2,F3	$59.75	Jun 29, 2015	M	2,407	D	Jan 18, 2012	Jan 18, 2019	Common Stock	2,407	7,223	D
Employee Stock Option (Right to Buy)^F3	$64.80	Jun 29, 2015	M	8,147	D	Jan 16, 2013	Jan 16, 2020	Common Stock	8,147	8,148	D

F1Date shown is the date of grant. These options vest ratably over a period of three years commencing on the first anniversary of the grant date, provided the reporting person satisfies certain service conditions.
F2Only represents the derivative securities in this class.
F3Date shown is the date of grant. These options vest ratably over four years commencing on the first anniversary of the grant date, provided the reporting person satisfies certain service conditions.